Pregnancy, nursing female subjects, or subjects trying to conceive

Clinically significant neurologic, cardiovascular, hepatic, renal, endocrinologic, pulmonary, hematological, psychiatric, or other medical illness that would interfere with participation in this study

History of ECG abnormalities

Cancer not in complete remission for at least 5 years

Clinically significant, symptomatic prostatic hypertrophy

Male subjects with a trans-urethral resection of the prostate or full resection of the prostate within 6 months prior to Screening

Clinically significant bladder neck obstruction or urinary retention

Inadequately treated glaucoma

History of an allergic reaction or hypersensitivity to any drug or to any component of the formulations used in this study

Subjects with pre-existing anemia and/or iron deficiency

Pharmacokinetics and Safety Study of PT010 in Healthy Subjects

What this study is about